- Sort by:
- Browse by:
- Free
- slides video
- audio + slides
- All slides included
Title to be announced
Scott D Jewell
Van Andel Research Inst., Grand Rapids, MI, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Catriona H M Jamieson
UCSD Moores Cancer Ctr., La Jolla, CA, United States
- Free
- audio only
- Audio only
Invited Speaker
Christopher A Maher
Washington Univ. School of Medicine, McDonnell Genome Institute, Saint Louis, MO, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Myles A Brown
Dana-Farber Cancer Inst., Boston, MA, United States
- Free
- Coming soon
- All slides included
Invited Speaker
Michael N. Pollak
McGill Univ., Montréal, QC, Canada
- Permission not
granted for presentation
Invited Speaker
Owen Sansom
Beatson Inst. for Cancer Research, Glasgow, United Kingdom
- Free
- audio + slides
- Some slides withheld
Invited Speaker
Ralph Scully
Beth Israel Deaconess Medical Ctr., Boston, MA, United States
- Free
- audio + slides
- Some slides withheld
Invited Speaker
Heiko Schoder
Memorial Sloan Kettering Cancer Center, New York, NY, United States
- Free
- audio + slides
- Some slides withheld
Invited Speaker
Martin G Pomper
Johns Hopkins Sidney Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
- Free
- audio + slides
- Some slides withheld
Invited Speaker
Kunle Odunsi
Roswell Park Cancer Inst., Buffalo, NY, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Paul Workman
The Institute of Cancer Research, London, United Kingdom
- Free
- slides video
- audio + slides
- All slides included
Introduction
Obi Lee Griffith
Washington University School of Medicine, Saint Louis, MO, United States
- Free
- podium video
- audio + slides
- Some slides withheld
Tumor genomic profiling to identify therapeutic biomarkers and guide clinical care
Michael F. Berger
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
- Free
- slides video
- audio + slides
- All slides included
Pharmacogenomics of chemotherapeutic-induced toxicities: Challenges and opportunities
M. Eileen Dolan
Univ. of Chicago, Chicago, IL, United States
- Free
- slides video
- audio + slides
- All slides included
Chromatin remodeling machines in cancer: New mechanisms and therapeutic opportunities
Cigall Kadoch
Dana-Farber Cancer Inst., Boston, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Oncohistones in cancer: How to turn a cell’s symphony into non harmonic rap?
Nada Jabado
McGill Univ., Montréal, QC, Canada
- Free
- podium video
- audio + slides
- Some slides withheld
Opportunities/Challenges for the Future
Obi Lee Griffith
Washington University School of Medicine, Saint Louis, MO, United States
- Free
- audio + slides
- Some slides withheld
Deactivating the innate immune defense mechanism of pancreatic cancer
Kian-Huat Lim
Washington Univ. School of Medicine, McDonnell Genome Institute, St Louis, MO, United States
- Free
- audio only
- Audio only
Targeting downstream effectors of KRAS via MEK and CDK-4 inhibition in PDAC
Michael N. Vansaun
Univ. of Miami, Miami, FL, United States
- Free
- audio + slides
- Some slides withheld
Use of PARP1 inhibitors to leverage a tumor-selective ‘kiss of death’
David A Boothman
Indiana University School of Medicine, Indianapolis, IN, United States
- Free
- audio + slides
- Some slides withheld
Clinical development of a tumor-penetrating peptide for enhanced pancreatic cancer therapy
Kazuki Sugahara
Columbia University, Herbert Irving Comprehensive Cancer Center, New York, NY, United States
- Free
- audio + slides
- Some slides withheld
Disparities in the use of targeted therapies for breast cancer
Katherine Reeder-Hayes
University Of North Carolina At Chapel Hil, Chapel Hill, NC, United States
- Free
- slides video
- audio + slides
- All slides included
Crossing the Divide: Disparities in access to personalized medicine for lung cancer
Christopher S Lathan
Dana-Farber Cancer Inst., Boston, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Toward a more sustainable path for targeted cancer drugs
Justin Bekelman
Abramson Cancer Ctr. of Univ. of Penn., Philadelphia, PA, United States
- Permission not
granted for presentation
Exploring the biologyof T Cell exhaustion
Crystal L Mackall
Stanford Univ. School of Medicine, Stanford, CA, United States